Uncategorized

Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo

Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo

Published

on

Now Eli Lilly has an obesity pill, too.

On Wednesday, the FDA approved orforglipron, the agency announced. It will be sold as Foundayo, and Lilly has previously said it plans to …​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version